| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/30/2001 | WO2001063279A2 Method of identifying toxic agents using differential gene expression |
| 08/30/2001 | WO2001063278A2 Antigenic fragments associated with stress-induced proteins and their use as vaccines |
| 08/30/2001 | WO2001062972A1 Methods for identifying candidate polynucleotide molecules encoding a protease |
| 08/30/2001 | WO2001062970A1 Methods and compositions for identifying a protease |
| 08/30/2001 | WO2001062969A2 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | WO2001062968A2 Mutant nucleic binding enzymes and use thereof in diagnostic, detection and purification methods |
| 08/30/2001 | WO2001062942A2 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 08/30/2001 | WO2001062937A1 Skin infection-related retroviral sequences |
| 08/30/2001 | WO2001062936A2 Bunyaviridal reaper proteins and uses therefor |
| 08/30/2001 | WO2001062935A1 A process for constructing dna based molecular marker for enabling selection of drought and diseases resistant germplasm screening |
| 08/30/2001 | WO2001062933A2 Muteins of interleukin-13 (il-13) |
| 08/30/2001 | WO2001062932A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 08/30/2001 | WO2001062930A1 Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| 08/30/2001 | WO2001062929A2 Sodium/solute symporter-like protein and nucleic acids encoding same |
| 08/30/2001 | WO2001062928A2 Polypeptides and nucleic acids encoding same |
| 08/30/2001 | WO2001062927A2 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics |
| 08/30/2001 | WO2001062926A2 44576, a novel g-protein coupled receptor and uses therefor |
| 08/30/2001 | WO2001062924A2 Human g protein-coupled receptors |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062922A2 Polypeptides and corresponding molecules for disease detection and treatment |
| 08/30/2001 | WO2001062921A2 Novel human regulatory protein and polynucleotides encoding the same |
| 08/30/2001 | WO2001062920A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 08/30/2001 | WO2001062919A1 Modified fluorescent proteins |
| 08/30/2001 | WO2001062918A2 Secretory polypeptides and corresponding polynucleotides |
| 08/30/2001 | WO2001062917A1 Isolated genomic sequences which encode the ny-eso-1 cancer testis tumor antigen and uses thereof |
| 08/30/2001 | WO2001062916A1 Novel armadillo repeat-containing protein alex1 |
| 08/30/2001 | WO2001062915A1 Novel protein and gene encoding the same |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062913A1 Vertebrate globin |
| 08/30/2001 | WO2001062912A2 Method of modulating glycosylation pathways |
| 08/30/2001 | WO2001062908A2 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062897A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines |
| 08/30/2001 | WO2001062896A2 Xa21-SPECIFIC AVIRULENCE DETERMINANTS FROM XANTHOMONAS ORYZAE PV. ORYZAE |
| 08/30/2001 | WO2001062893A2 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 08/30/2001 | WO2001062891A2 207 human secreted proteins |
| 08/30/2001 | WO2001062799A2 Method for inhibiting angiogenesis using molecules that enhance plasmin activity |
| 08/30/2001 | WO2001062798A2 G protein-coupled receptors |
| 08/30/2001 | WO2001062797A2 G protein-coupled receptors |
| 08/30/2001 | WO2001062796A1 Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis |
| 08/30/2001 | WO2001062795A1 COMPOUNDS RELATED TO OR DERIVED FROM GFRα4 AND THEIR USE |
| 08/30/2001 | WO2001062794A2 18607, a human calcium channel |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062792A2 Cancer treatment and prognosis involving hes-1 protein |
| 08/30/2001 | WO2001062791A2 Control of tgf (beta) signaling by km23 superfamily members |
| 08/30/2001 | WO2001062790A2 Nuclear factor polypeptides and nucleic acids encoding same |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062788A2 Corneodesmosin based test and model for inflammatory disease |
| 08/30/2001 | WO2001062787A1 Diagnosis and treatment of bipolar affective disorder |
| 08/30/2001 | WO2001062786A2 Tlp peptides and dna sequences coding the same |
| 08/30/2001 | WO2001062785A2 Protein and gene and their use for diagnosis and treatment of schizophrenia |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062783A1 A novel polypeptide-human split complex 69 and the polynucleotide encoding said polypeptide |
| 08/30/2001 | WO2001062782A1 A novel polypeptide-arrestin family 11 and the polynucleotide encoding said polypeptide |
| 08/30/2001 | WO2001062779A2 New transcription factor carp-2 |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062774A2 Purified lh |
| 08/30/2001 | WO2001062773A1 PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD |
| 08/30/2001 | WO2001062770A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | WO2001062767A1 IDENTIFICATION OF A cDNA ASSOCIATED WITH VENTRICULAR FUNCTION IN HUMAN MYOCARDIAL TISSUE |
| 08/30/2001 | WO2001062298A2 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 08/30/2001 | WO2001062286A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | WO2001062284A2 Novel method for down-regulation of amyloid |
| 08/30/2001 | WO2001062281A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 08/30/2001 | WO2001062271A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/30/2001 | WO2001062239A2 Novel compositions and uses of dictyostatin compounds |
| 08/30/2001 | WO2001062076A1 Production of mammals which produce progeny of a single sex |
| 08/30/2001 | WO2001025421A3 Materials and method for detecting interaction of cftr polypeptides |
| 08/30/2001 | WO2001025400A3 Compositions and methods for modulating atp-binding cassette transmembrane reporter protein expression |
| 08/30/2001 | WO2001023568A3 Members of the iap gene family |
| 08/30/2001 | WO2001023420A3 Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
| 08/30/2001 | WO2001023419A3 Differentially expressed genes |
| 08/30/2001 | WO2001014519A3 Methods and compositions for regulating developmental identity |
| 08/30/2001 | WO2001014408A3 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 08/30/2001 | WO2001012823A3 Macular degeneration diagnostics and therapeutics |
| 08/30/2001 | WO2001012806A3 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 08/30/2001 | WO2001012801A3 Defense-related signaling genes and methods of use |
| 08/30/2001 | WO2001012776A3 18 human secreted proteins |
| 08/30/2001 | WO2001012658A3 Human icos ligand and application thereof |
| 08/30/2001 | WO2001012127A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 08/30/2001 | WO2001011039A3 New sequence variants of the human 1-adrenoreceptor gene and use thereof |
| 08/30/2001 | WO2001010900A3 Globular assembly of amyloid beta protein and uses thereof |
| 08/30/2001 | WO2001009350A3 Genetically engineered bleb vaccine |
| 08/30/2001 | WO2001009325A3 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/30/2001 | WO2001009187A3 Human monoclonal antibodies to her2/neu |
| 08/30/2001 | WO2001009174A3 Plant defensin variants |
| 08/30/2001 | WO2001008702A3 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 08/30/2001 | WO2001002568A3 Human genes and gene expression products |
| 08/30/2001 | WO2000078965A3 Plant auxin proteins |
| 08/30/2001 | WO2000050563A9 G protein-coupled receptor resembling galanin receptors |
| 08/30/2001 | WO2000047738A9 Human and mouse trek-1 potassium channel protein and their use |
| 08/30/2001 | WO2000041719A9 Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders |
| 08/30/2001 | WO2000040614A9 Characterization of the soc/crac calcium channel protein family |
| 08/30/2001 | US20010018773 Production of cotton fiber with improved fiber characteristics |
| 08/30/2001 | US20010018512 For biopolymer |
| 08/30/2001 | US20010018511 Anticancer agent |
| 08/30/2001 | US20010018509 Growth differeniation factor-3 |
| 08/30/2001 | US20010018427 Anticholesterol agent |
| 08/30/2001 | US20010018421 Polypeptides |
| 08/30/2001 | US20010018420 Method for alleviating pain or providing an analgesic effect in a patient |